基于AQP4的化学免疫吸收剂,用于从血液中高特异性去除AQP4-IgG

Xiaofei Wang1, Fangling Ji1, Lingyun Jia1

  • 1MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning 116023, China; Liaoning Key Laboratory of Molecular Recognition and Imaging, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning 116023, China.

PubMed
概括

研究人员开发了一种针对抗aquaporin-4自身抗体 (AQP4-IgG) 的新型免疫吸收剂,用于治疗神经omyelitis optica光谱障碍 (NMOSD). 这种特定的AQP4-IgG去除系统提供了一个有前途的新疗法.